# BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

Study · id `cardio:ct-nct01603615` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01603615](<https://clinicaltrials.gov/study/NCT01603615>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01603615

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 220 participants.

## Technical summary

Registry record NCT01603615. Allocation not applicable; no masking; primary purpose treatment. Start 2012-10-30 (actual); primary completion 2018-09-03 (actual). Results posted on 2019-08-21.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 220 participants (enrolled count; ClinicalTrials.gov record NCT01603615, source copy `cardio:ctgov-nct01603615-2019-08-21`, retrieved 2026-10-26)
- Started: 2012-10-30 (actual) (ClinicalTrials.gov record NCT01603615, source copy `cardio:ctgov-nct01603615-2019-08-21`, retrieved 2026-10-26)
- Primary completion: 2018-09-03 (actual) (ClinicalTrials.gov record NCT01603615, source copy `cardio:ctgov-nct01603615-2019-08-21`, retrieved 2026-10-26)
- Completion: 2018-09-03 (actual) (ClinicalTrials.gov record NCT01603615, source copy `cardio:ctgov-nct01603615-2019-08-21`, retrieved 2026-10-26)
- Results first posted: 2019-08-21 (ClinicalTrials.gov record NCT01603615, source copy `cardio:ctgov-nct01603615-2019-08-21`, retrieved 2026-10-26)
- Countries: United States; Canada; Hungary; Philippines; Poland; Russia; South Korea; Thailand; Türkiye (ClinicalTrials.gov record NCT01603615, source copy `cardio:ctgov-nct01603615-2019-08-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01603615-2019-08-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
- Condition: Pediatrics
- Condition: Muscle Spasticity
- Condition: Cerebral Palsy
- Condition: Stroke
- Intervention (Biological): Botulinum Toxin Type A
- Lead sponsor: Allergan
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 2b16722da0360171157e12098b9f1200e68f89b7338035d10425721a8bfc85b7
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
